Abstract
Immunotherapies have shown efficacy in improving autoimmune conditions such as rheumatoid arthritis and are now widely established for various cancer entities. Nevertheless, predicting patient outcomes prior to therapy remains very challenging, likely attributable to the diversity and complex, interactive dynamics of immune cells. Recent advancements in statistical analysis as well as machine learning and mathematical modeling techniques have provided insights into immune-cell regulation and tumor-immune dynamics. Here, we discuss recent developments in this field, with the aim of deriving a path to improvements in treatment biomarker identification and adverse effect prediction. Deriving a quantitative understanding of the complex interactions among immune cell subpopulations holds promise for optimizing treatment strategies in numerous health conditions from chronic inflammation to cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
